Literature DB >> 10214827

Altered cord serum lipid levels associated with small for gestational age infants.

J N Jones1, C Gercel-Taylor, D D Taylor.   

Abstract

OBJECTIVE: To determine whether small for gestational age (SGA) infants show changes in lipid metabolism that could distinguish growth-restricted subpopulations.
METHODS: Sera from the arterial cord blood from 38 SGA infants were analyzed for apolipoprotein A-I level, total lipid content, and distribution of those lipids as triglycerides, diglycerides, free fatty acids, and phospholipids. Comparisons were made between appropriate for gestational age (AGA) controls (n = 25), SGA infants with a ponderal index below the tenth percentile (SGA I, n = 20), and SGA infants with a ponderal index above the tenth percentile (SGA II, n = 18).
RESULTS: Total cord serum lipid content was markedly decreased in all SGA infants compared with AGA infants (2.8 times lower). Although SGA infants showed total lipid concentration decreases, SGA I and SGA II infants showed distinct characteristics. Infants in the SGA I group had higher triglyceride levels (1.8 times higher) and lower free fatty acid levels (1.4 times lower), compared with AGA infants (P < .001). The lipid subclass distribution in SGA II infants was not significantly different from that in AGA infants, with the exception of an increase in triglyceride concentrations (1.3 times higher). Although the 22-kD placenta-derived apolipoprotein A-I was similar in all groups, the level of fetal liver-derived 28-kD apolipoprotein A-I was 6.5 times lower in SGA I infants than in AGA or SGA II infants (P < .001).
CONCLUSION: The SGA I infants appeared to have impaired utilization of circulating triglycerides, consistent with peripheral adipose depletion. Diminished fetus-derived apolipoprotein A-I levels with normal levels of placenta-derived apolipoprotein A-I levels might indicate a defect in the production or secretion of apolipoproteins associated with growth restriction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10214827     DOI: 10.1016/s0029-7844(98)00489-x

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Dietary Tryptophan Supplementation Alters Fat and Glucose Metabolism in a Low-Birthweight Piglet Model.

Authors:  Parniyan Goodarzi; Mohammad Habibi; Kennedy Roberts; Julia Sutton; Cedrick Ndhumba Shili; Dingbo Lin; Adel Pezeshki
Journal:  Nutrients       Date:  2021-07-26       Impact factor: 6.706

2.  Liver Proteome Profile of Growth Restricted and Appropriately Grown Newborn Wistar Rats Associated With Maternal Undernutrition.

Authors:  Polyxeni-Maria Sarli; Antigoni Manousopoulou; Elias Efthymiou; Andreas Zouridis; Anastasios Potiris; Panagiota Pervanidou; Konstantinos Panoulis; Nikolaos Vlahos; Efthymios Deligeoroglou; Spiros D Garbis; Makarios Eleftheriades
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-28       Impact factor: 5.555

3.  Insulin resistance and adiponectin levels are associated with height catch-up growth in pre-pubertal Chinese individuals born small for gestational age.

Authors:  Hong-Zhu Deng; Hong Deng; Zhe Su; Yan-Hong Li; Hua-Mei Ma; Hong-Shan Chen; Min-Lian Du
Journal:  Nutr Metab (Lond)       Date:  2012-11-28       Impact factor: 4.169

4.  Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus.

Authors:  Ute M Schaefer-Graf; Kristof Graf; Irina Kulbacka; Siri L Kjos; Joachim Dudenhausen; Klaus Vetter; Emilio Herrera
Journal:  Diabetes Care       Date:  2008-07-07       Impact factor: 19.112

5.  Metabolic profiling and targeted lipidomics reveals a disturbed lipid profile in mothers and fetuses with intrauterine growth restriction.

Authors:  Jezid Miranda; Rui V Simões; Cristina Paules; Daniel Cañueto; Miguel A Pardo-Cea; María L García-Martín; Francesca Crovetto; Rocio Fuertes-Martin; Monica Domenech; María D Gómez-Roig; Elisenda Eixarch; Ramon Estruch; Stefan R Hansson; Nuria Amigó; Nicolau Cañellas; Fatima Crispi; Eduard Gratacós
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.